| Multinominal logistic regression (using APOA1 rs670 G/G as reference) | |||||
---|---|---|---|---|---|---|
 | APOA1 rs670 G/A | APOA1 rs670 A/A | ||||
 | OR | 95% Cl | P value | OR | 95% Cl | P value |
Tumor type (using infiltrating ductal carcinoma as reference) | ||||||
Ductal carcinoma in situ | 0.38 | 0.12-1.15 | 0.086 | 0.64 | 0.13-3.11 | 0.575 |
Others | 0.6 | 0.16-2.32 | 0.461 | 1.27 | 0.23-6.99 | 0.784 |
Unknown | 0 | 0-0 | N/A | 0 | 0-0 | N/A |
Side (using right as reference) | ||||||
Left | 0.66 | 0.37-1.18 | 0.160 | 0.69 | 0.28-1.66 | 0.402 |
Bilateral | 0.67 | 0.16-2.87 | 0.593 | 0.67 | 0.07-6.59 | 0.734 |
Tumor size (using <5cm as reference) | ||||||
≥5cm | 2.25 | 0.83-6.08 | 0.111 | 2.25 | 0.57-8.79 | 0.245 |
Unknown | 0.59 | 0.28-1.26 | 0.173 | 0.67 | 0.21-2.21 | 0.515 |
Lymph node involvement (using positive as reference) | ||||||
Negative | 3.32 | 1.77-6.20 | <0.001 | 2.58 | 1.05-6.32 | 0.039 |
Unknown | 0.95 | 0.28-3.18 | 0.930 | 0 | 0-0 | N/A |
TMN staging (using stages 0–2 as reference) | ||||||
Stages >2 | 2.41 | 0.95-6.11 | 0.064 | 1.8 | 0.48-6.79 | 0.385 |
Unknown | 0.71 | 0.34-1.49 | 0.364 | 0.47 | 0.13-1.76 | 0.263 |
ER/PR status (using positive as reference) | ||||||
Negative | 1.85 | 0.88-3.92 | 0.106 | 4.85 | 1.83-12.83 | 0.001 |
Unknown | 0.79 | 0.34-1.85 | 0.592 | 0.35 | 0.04-2.87 | 0.326 |
Family history (using negative as reference) | ||||||
Positive | 0.63 | 0.14-2.88 | 0.548 | 0 | 0-0 | N/A |
Unknown | 1 | 0.30-3.40 | 0.997 | 1.3 | 0.24-7.09 | 0.765 |